2014
DOI: 10.1016/j.amjcard.2014.07.059
|View full text |Cite
|
Sign up to set email alerts
|

Meta-Analysis on Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 23 publications
0
28
0
2
Order By: Relevance
“…CI-AKI is the third most common cause of hospital acquired acute renal failure [2, 4, 5] and is responsible for about 10–12% of the cases [2, 68]. Renal function may deteriorate after RCM use even in the absence of overt CI-AKI [9, 10].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…CI-AKI is the third most common cause of hospital acquired acute renal failure [2, 4, 5] and is responsible for about 10–12% of the cases [2, 68]. Renal function may deteriorate after RCM use even in the absence of overt CI-AKI [9, 10].…”
Section: Introductionmentioning
confidence: 99%
“…The rise in the use of intravenous RCM for computer tomography (CT) and magnetic resonance imaging (MRI) and angiography [5] (Figure 1) led to the recognition of CI-AKI as the most important complication of iodinated RCM administration. Although contrast enhanced X-ray is the most common indication of RCM use (Figure 1), percutaneous coronary angiography (in the USA: 1.4–1.3 million/year between 1997 and 2010 [12]) is the primary cause of CI-AKI [4, 5]. Although hydration is considered to be the most effective preventive measure [13, 14], CI-AKI may develop in 3–25% of patients despite appropriate hydration [15] and further preventive measures such as antioxidants [2, 16] or statins [4, 17].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, several randomized trials reported that pretreatment statin therapy, in particular strong statins, modestly reduces the incidence of Contrast-Induced Acute Kidney Injury in addition to lowering lipid levels in patients undergoing coronary angiography [27,28]. However, there were no significant relationships between CIN incidences and the presence or absence of pretreatment statin in the present study.…”
Section: Discussionmentioning
confidence: 65%
“…[25][26][27][28][29] Perhaps this could be due to differences in AKI risk profiles among patients who undergo vascular surgery procedures or the specific drug or dose delivered. Additionally, our study was likely underpowered to detect these differences.…”
Section: Discussionmentioning
confidence: 99%